China SXT Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-1.161; its P/E ratio is -0.85; China SXT Pharmaceuticals is scheduled to report earnings on February 1, 2021, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 23	Sep 22	Mar 22	Sep 21	Mar 21
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	-	-	-	-	-
EBITDA	-	-	-	-	-
Net Income Common Stockholders	-	-	-	-	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 17.37M	$ 2.98M	$ 15.52M	$ 31.32K	$ 13.33M
Total Assets	$ 29.55M	$ 22.18M	$ 33.55M	$ 22.67M	$ 34.55M
Total Debt	$ 599.23K	$ 1.21M	$ 2.05M	$ 24.04K	$ 43.41K
Net Debt	$ -16.77M	$ -1.77M	$ -13.48M	$ -7.28K	$ -13.29M
Total Liabilities	$ 14.86M	$ 7.29M	$ 17.12M	$ 8.88M	$ 18.59M
Stockholders Equity	$ 14.69M	$ 14.89M	$ 16.42M	$ 13.79M	$ 15.96M
Cash Flow	-
Free Cash Flow	-	-	-	-	-
Operating Cash Flow	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-

Currency in USD

China SXT Pharmaceuticals Earnings and Revenue History

Income Statement >

China SXT Pharmaceuticals Debt to Assets

Balance Sheet >

China SXT Pharmaceuticals Cash Flow

Cash Flow >

China SXT Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing